New Alzheimer’s Treatment Targets cPLA2 Enzyme
USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.
RiboNN: AI Boosts mRNA Therapy & Vaccine Design
RiboNN, a new AI model, predicts mRNA translation efficiency, enhancing protein production for therapies and vaccines. Developed by UT Austin & Sanofi, it accelerates drug discovery by reducing trial-and-error.
Aspergillus Flavus Fungus: Novel Cancer Treatment Discovery
Scientists extracted asperigimycins from Aspergillus flavus, a fungus, showing potential against leukemia cells. Bioengineered fungal RiPPs disrupt cancer cell division with high specificity, equalling FDA drugs.